Pharmacoepidemiology and Drug Safety

Papers
(The TQCC of Pharmacoepidemiology and Drug Safety is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Time‐related biases in pharmacoepidemiology74
Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms66
Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): A data resource for pharmacoepidemiology in Spain43
Rise and regional disparities in buprenorphine utilization in the United States43
Accuracy of Japanese claims data in identifying diabetes‐related complications38
Control yourself: ISPE‐endorsed guidance in the application of self‐controlled study designs in pharmacoepidemiology34
Considerations for pharmacoepidemiological analyses in the SARS‐CoV‐2 pandemic33
CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities31
Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators30
QTc prolongation in COVID‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta‐analysis28
Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trials27
Analysis of immune‐related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database25
Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism25
Validation of diagnosis codes to identify hospitalized COVID‐19 patients in health care claims data24
Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death23
Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006‐2016: A study in the five Nordic countries, United States, and Australia22
Suicide‐related over‐the‐counter analgesic exposures reported to United States poison control centers, 2000‐201821
Identifying drugs with disease‐modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology21
A COVID‐19‐ready public health surveillance system: The Food and Drug Administration's Sentinel System21
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 320
Randomized, observational, interventional, and real‐world—What's in a name?20
Genetic and clinical risk factors associated with phenytoin‐induced cutaneous adverse drug reactions in Thai population20
Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning19
Considerations when evaluating real‐world data quality in the context of fitness for purpose19
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry19
Antidepressant use in Australia and Sweden—A cross‐country comparison19
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data19
Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: Consequences and statistical approaches19
Interventions to improve adverse drug reaction reporting: A scoping review19
Sodium‐glucose cotransporter‐2 inhibitors and the risk of gout: A Danish population based cohort study and symmetry analysis18
Safety of Andrographis paniculata: A systematic review and meta‐analysis18
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force17
A national study on prescribed medicine use in Australia on a typical day17
Assessing the impact of unmeasured confounders for credible and reliable real‐world evidence17
A behavioral economics‐based telehealth intervention to improve aspirin adherence following hospitalization for acute coronary syndrome16
Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study16
Translational hurdles with cannabis medicines16
Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population‐based cohort studies16
Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data16
Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence 16
Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom16
Risk of incident dementia following metformin initiation compared with noninitiation or delay of antidiabetic medication therapy15
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study15
Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave15
Real‐world evidence to support regulatory decision making: New or expanded medical product indications15
Validation of diagnostic coding for interstitial lung diseases in an electronic health record system in Hong Kong15
Validation of algorithms to identify adverse perinatal outcomes in the Medicaid Analytic Extract database15
Evaluation of more than one billion outpatient prescriptions and eight‐year trend showing a remarkable reduction in antibiotic prescription in Turkey: A success model of governmental interv14
Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom14
Impact of medication nonadherence on stroke recurrence and mortality in patients after first‐ever ischemic stroke: Insights from registry data in Singapore14
Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States13
Incorporating patient generated health data into pharmacoepidemiological research13
Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract—Quantifying the misclassification of maternal drug exposure during pregnancy13
Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: A retrospective cohort study13
Medication burden and frailty in older adults with intellectual disability: An observational cross‐sectional study13
Assessing the effects of beta‐blockers on pancreatic cancer risk: A nested case‐control study13
Incidence rates of and risk factors for opioid overdose in new users of prescription opioids among US Medicaid enrollees: A cohort study13
The association between aspirin use and depression: a systematic review and meta‐analysis of observational studies12
The Chang Gung Research Database: Multi‐institutional real‐world data source for traditional Chinese medicine in Taiwan12
Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes12
Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products12
Validation of an ICD‐10‐based algorithm to identify stillbirth in the Sentinel System12
National pharmacovigilance programs in Arab countries: A quantitative assessment study12
Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data12
Effects of sodium glucose cotransporter 2 inhibitors on risk of dyslipidemia among patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials11
Identifying prescribing cascades in Alzheimer's disease and related dementias: The calcium channel blocker‐diuretic prescribing cascade11
Risk of myopericarditis following COVID‐19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods11
Effect of ICD‐9‐CM to ICD‐10‐CM coding system transition on identification of common conditions: An interrupted time series analysis11
Validity of congenital malformation diagnoses in healthcare claims from a university hospital in Japan11
Identification of pregnancies and infants within a US commercial healthcare administrative claims database11
Optimizing identification of resistant hypertension: Computable phenotype development and validation11
Trends in fall‐related mortality and fall risk increasing drugs among older individuals in the United States,1999–201711
Preparing for COVID‐19 vaccine safety surveillance: A United States perspective11
Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims data11
Challenges facing drug utilization research in the Latin American region11
Global COVID‐19 pandemic and reporting behavior ‐ An analysis of the Food and Drug Administration adverse events reporting system11
Validity of ICD‐10‐CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies11
Trends in strong opioid prescribing in Ireland: A repeated cross‐sectional analysis of a national pharmacy claims database between 2010 and 201911
Use of negative controls in a prescription sequence symmetry analysis to reduce time‐varying bias10
Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data10
Chronic pain patients' willingness to share personal identifiers on the web for the linkage of medico‐administrative claims and patient‐reported data: The chronic pain treatment cohort10
Building an active medical product safety surveillance system in Taiwan: Adaptation of the U.S. Sentinel System common data model structure to the National Health Insurance Research Database in Taiwan10
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data10
Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence10
Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims10
Using artificial intelligence to identify anti‐hypertensives as possible disease modifying agents in Parkinson's disease10
Drug exposure misclassification in pharmacoepidemiology: Sources and relative impact10
Developing algorithms for identifying major structural birth defects using automated electronic health data10
Effectiveness of risk minimisation measures for valproate: A drug utilisation study in Europe10
Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication10
Validity of claims‐based algorithms to identify neurodevelopmental disorders in children10
Use of hydrochlorothiazide and risk of skin cancer in a large nested case‐control study in Spain10
Medication‐related problems in older people in Catalonia: A real‐world data study9
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?9
A systematic review of how missing data are handled and reported in multi‐database pharmacoepidemiologic studies9
Reporting and variability of constructing medication treatment episodes in pharmacoepidemiology studies: A methodologic systematic review using the case study of DPP‐4 inhibitors and cardio9
A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States ‐ 2007 to 20169
Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real‐world healthcare databases9
Postoperative inpatient utilization of opioid and opioid‐sparing analgesics in the United States hospitals, 2007–20179
Multimorbidity measures from health administrative data using ICD system codes: A systematic review9
Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real‐world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from lar9
Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, China9
Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?9
Using administrative healthcare database records to study trends in prescribed medication dispensed during pregnancy in Belgium from 2003 to 20179
Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data9
Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid‐related adverse drug reactions in the FDA database over 15 years8
Medication persistence of targeted immunomodulators for plaque psoriasis: A retrospective analysis using a U.S. claims database8
Categorization of COVID‐19 severity to determine mortality risk8
Nonsteroidal anti‐inflammatory drugs associated acute kidney injury in hospitalized children: A systematic review and meta‐analysis8
Overview of the European post‐authorisation study register post‐authorization studies performed in Europe from September 2010 to December 20188
Using machine learning to identify diabetes patients with canagliflozin prescriptions at high‐risk of lower extremity amputation using real‐world data8
Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland8
Greedy caliper propensity score matching can yield variable estimates of the treatment‐outcome association—A simulation study8
Impact of adherence to drugs for secondary prevention on mortality and cardiovascular morbidity: A population‐based cohort study. IMPACT study8
Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas8
Bias in case‐crossover studies of medications due to persistent use: A simulation study8
Performance assessment of different machine learning approaches in predicting diabetic ketoacidosis in adults with type 1 diabetes using electronic health records data8
Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross‐sectional patient‐reported survey data8
ICPE All Access conference abstracts8
Impact of variable look‐back periods on the incidence rates of chronic diseases using real world data8
7
Health outcomes coding trends in the US Food and Drug Administration's Sentinel System during transition to International Classification of Diseases‐10 coding system: A brief review7
COVID‐19 pharmacotherapy utilization patterns during pregnancy: International Registry of Coronavirus Exposure in Pregnancy7
Risk of common infections among individuals with psoriasis in Sweden: A nationwide cohort study comparing secukinumab to ustekinumab7
New‐user and prevalent‐user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices7
Using the waiting time distribution with random index dates to estimate prescription durations in the presence of seasonal stockpiling7
Association between antidepressant use in pregnancy and gestational diabetes mellitus: Results from the Norwegian Mother, Father and Child Cohort Study7
Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies7
Sulphonylureas monotherapy and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: A population‐based cohort study in China7
The utility of real‐world evidence for benefit‐risk assessment, communication, and evaluation of pharmaceuticals: Case studies7
High‐dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting7
Interrupted time series analysis to assess changes in prescription filling around conception and implications for exposure misclassification7
Estimation of adverse drug reaction reporting in Iran: Correction for underreporting7
Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes7
Real‐world data in Saudi Arabia: Current situation and challenges for regulatory decision‐making7
Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada7
Use of a mobile app to capture supplemental health information during pregnancy: Implications for clinical research7
Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade7
Thromboembolic events after Ad.26.COV2.S COVID‐19 vaccine: Reports to the Vaccine Adverse Event Reporting System6
Use of negative control outcomes to assess the comparability of patients initiating lipid‐lowering therapies6
Validity of identification algorithms combining diagnostic codes with other measures for acute ischemic stroke in MID‐NET®6
Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States6
Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system6
Where to begin? Thirty must‐read papers for newcomers to pharmacoepidemiology6
Effect of concomitant antiplatelet therapy on ischemic and hemorrhagic events in patients taking oral anticoagulants for nonvalvular atrial fibrillation in daily clinical practice6
Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes6
Emergency hospitalizations for adverse drug events in China: Clinical pharmacists' approach to assessment and categorization6
Very high PD‐L1 expression as a prognostic indicator of overall survival among patients with advanced non‐small cell lung cancer receiving anti‐PD‐(L)1 monotherapies i6
Differential frequency in imaging‐based outcome measurement: Bias in real‐world oncology comparative‐effectiveness studies6
Rapid monitoring of health services utilization following a shift in coverage from brand name to biosimilar drugs in British Columbia—An interim report6
Alzheimer's disease and related dementias risk: Comparing users of non‐selective and M3‐selective bladder antimuscarinic drugs6
An investigation on the association between sodium glucose co‐transporter 2 inhibitors use and acute pancreatitis: A VigiBase study6
More extreme duplication in the U.S. FDA FAERS database and a suggested check point for disproportionality analysis6
Drug product dispensing and estimates of use in a general population survey as a signal detection problem6
Relation between anticholinergic burden and cognitive impairment: Results from the Monzino 80‐plus population‐based study6
SGLT‐2 inhibitors and the risk of hospitalization for community‐acquired pneumonia: A population‐based cohort study6
A systematic review and meta‐analysis of observational studies of the association between the use of incretin‐based therapies and the risk of pancreatic cancer6
Validation of diagnosis codes in healthcare databases in Taiwan, a literature review6
Pharmacoepidemiology of testosterone: Impact of reimbursement policy on curbing off‐label prescribing6
Use of hydrochlorothiazide in Denmark following publication of skin cancer risk findings6
Impact of direct‐acting antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers6
Hydrochlorothiazide and risk of melanoma subtypes6
Medical device active surveillance of spontaneous reports: A literature review of signal detection methods6
Trends in the use of disease‐modifying therapies among reproductive‐aged women with multiple sclerosis in the United States from 2010 to 20196
Attention‐deficit/hyperactivity disorder medication and risk of suicide attempt: A meta‐analysis of observational studies6
Chronic prescription opioid use in pregnancy in the United States6
Time‐related biases in perinatal pharmacoepidemiology: A systematic review of observational studies6
Ondansetron use in early pregnancy and the risk of late pregnancy outcomes6
6
Treatment resistant depression incidence and prevalence using the French nationwide claims database6
High concordance between chart review adjudication and electronic medical record data to identify prevalent and incident diabetes mellitus among persons with and without HIV6
Identifying frequent drug combinations associated with delirium in older adults: Application of association rules method to a case‐time‐control design6
Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review6
Pharmacovigilance network as an additional tool for the surveillance of antimicrobial resistance6
Validity of a model using routinely collected data for identifying infections following gastric, colon, and liver cancer surgeries6
Data sources for drug utilization research in Latin American countries—A cross‐national study: DASDUR‐LATAM study6
Tenofovir disoproxil fumarate associated nephrotoxicity: a retrospective cohort study at two referral hospitals in Namibia6
Assessing polypharmacy in the older population: Comparison of a self‐reported and prescription based method5
Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases5
Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 20165
5
Feasibility of using Clinical Practice Research Datalink data to identify patients with chronic obstructive pulmonary disease to enrol into real‐world trials5
In utero exposure to analgesic opioids and language development in 5‐year old children5
Ethnic inequality in non‐steroidal anti‐inflammatory drug‐associated harm in New Zealand: A national population‐based cohort study5
Prevalence and incidence rate of hospital admissions related to medication between 2008 and 2013 in The Netherlands5
No association between use of phosphodiesterase 5 inhibitors and colorectal cancer in men with erectile dysfunction5
Empirical assessment of case‐based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project5
Analysis of the US FDA adverse event reporting system to identify adverse cardiac events associated with hydroxychloroquine in older adults5
Nonsteroidal anti‐inflammatory drugs use in patients with chronic kidney disease are often prescribed from different clinicians than those who diagnosed them5
Association of baloxavir marboxil prescription with subsequent medical resource utilization among school‐aged children with influenza5
Real‐world effectiveness of pembrolizumab in previously treated non‐small cell lung cancer: A population‐based cohort study5
Prediction of post‐vaccination Guillain‐Barré syndrome using data from a passive surveillance system5
5
Suitability of databases in the Asia‐Pacific for collaborative monitoring of vaccine safety5
Acute kidney injury identification for pharmacoepidemiologic studies: Use of laboratory electronic acute kidney injury alerts versus electronic health records in Hospital Episode Statistics5
The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database5
Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database5
Validation of an electronic algorithm for Hodgkin and non‐Hodgkin lymphoma in ICD‐10‐CM5
Memantine misuse and social networks: A content analysis of Internet self‐reports5
Validation studies of Japanese administrative health care data: A scoping review5
Proton pump inhibitors may enhance the risk of citalopram‐ and escitalopram‐associated sudden cardiac death among patients receiving hemodialysis5
Mobile apps for quick adverse drug reaction report: A scoping review5
Drug discontinuation in pregnant women with psoriasis: The PSOMOTHER cohort study5
Identifying opioid dose reductions and discontinuation among patients with chronic opioid therapy5
Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data5
Off‐label drug use in neonates and infants in Spain: A five‐year observational study5
Association between domperidone use and adverse cardiovascular events: A nested case‐control and case‐time‐control study5
Signals from the Dutch national spontaneous reporting system: Characteristics and regulatory actions5
What types of real‐world evidence studies do U.S. commercial health plans cite in their specialty drug coverage decisions?5
Comparison of the incidence of bleeding between baloxavir marboxil and other anti‐influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment‐bas5
Risk of major congenital malformations associated with first‐trimester exposure to propulsives: A health administrative database study in Japan5
Impact of a nationwide prospective drug utilization review program to improve prescribing safety of potentially inappropriate medications in older adults: An interrupted time series with segmented reg5
Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting5
Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large‐scale COVID‐19 surveillance system4
Allopurinol‐induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia4
Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post‐authorization safety cohort study conducted in Europe and in the United States4
Comparing LASSO and random forest models for predicting neurological dysfunction among fluoroquinolone users4
Validation of venous thromboembolism diagnoses in patients receiving rivaroxaban or warfarin in The Health Improvement Network4
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies4
Pharmacological and epidemiological considerations while constructing treatment episodes using observational data: A simulation study4
Linkage of public health and all payer claims data for population‐level opioid research4
Baseline anticholinergic burden from medications predicts poorer baseline and long‐term health‐related quality of life in 16 675 men and women of EPIC‐Norfolk prospective population‐based c4
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries4
Increasing rates of buprenorphine diversion in the United States, 2002 to 20194
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy4
Association between pre‐admission anticoagulation and in‐hospital death, venous thromboembolism, and major bleeding among hospitalized COVID‐19 patients in Japan4
Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data4
Hepatic adverse drug reactions in Malaysia: An 18‐year review of the national centralized reporting system4
Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists4
Effectiveness of risk minimisation measures for valproate: A cross‐sectional survey among physicians in Europe4
Spillover effects of state medicaid antipsychotic prior authorization policies in US commercially insured youth4
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases4
Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data4
Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK‐based electronic health records database4
General practitioner prescribing trends among pediatric patients in the United Kingdom: 1998–20184
Medications used disproportionately during pregnancy: Priorities for research on the risks and benefits of medications when used during pregnancy4
Quantifying cumulative anticholinergic and sedative drug load among US Medicare Beneficiaries4
Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System4
Implementing high‐dimensional propensity score principles to improve confounder adjustment in UK electronic health records4
Ondansetron use in early pregnancy and the risk of miscarriage4
Risk of delirium associated with antimuscarinics in older adults: A case‐time‐control study4
The controversy around technical standards for similar biotherapeutics: barriers to access and competition?4
Meta‐analysis of the risk of autoimmune thyroiditis, Guillain‐Barré syndrome, and inflammatory bowel disease following vaccination with AS04‐adjuvanted human papillomavirus 16/184
Comparative risk of Parkinsonism associated with olanzapine, risperidone and quetiapine in older adults‐a propensity score matched cohort study4
Predicting obesity and smoking using medication data: A machine‐learning approach4
Perinatal pharmacoepidemiology: How often are key methodological elements reported in publications?4
Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe4
Real world data to identify target population for new CAR‐T therapies4
Bias of time‐varying exposure effects due to time‐varying covariate measurement strategies4
Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies4
0.072026014328003